Investor Alert

Market Pulse Archives

May 13, 2021, 4:50 p.m. EDT

GoodRx stock heads lower after mixed Q1 results

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    GoodRx Holdings Inc. (GDRX)

or Cancel Already have a watchlist? Log In

By Claudia Assis


Shares of GoodRX Holdings Inc. /zigman2/quotes/221104301/composite GDRX -3.13% fell more than 5% in the extended session Thursday after the health-care company reported first-quarter sales slightly below Wall Street expectations and met the forecast for adjusted profit. GoodRx said it earned $1.7 million, breaking even on a per-share basis, in the quarter, compared with $27.3 million, or 8 cents a share, in the year-ago quarter. Adjusted for one-time items, the company earned 7 cents a share. Sales rose 20% to $160.4 million, the company said. Analysts polled by FactSet expected GoodRX to earn an adjusted 7 cents a share on sales of $160.6 million. Monthly active consumers rose 17% to 5.7 million people, it said. GoodRX guided for second-quarter revenue between $172 million and $176 million, and full-year 2021 revenue between $740 million and $760 million. The stock ended the regular trading day down 4%.

US : U.S.: Nasdaq
$ 38.42
-1.24 -3.13%
Volume: 2.03M
Dec. 3, 2021 4:00p
P/E Ratio
Dividend Yield
Market Cap
$15.40 billion
Rev. per Employee

Get news alerts on GoodRx Holdings Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.